25 results
8-K
RENB
Renovaro Inc.
30 Apr 24
Other Events
4:49pm
groundbreaking multi-cancer detection model contributing to its mission to transform early cancer diagnostics. Leveraging ultra-low pass whole genome sequencing
DEFM14A
RENB
Renovaro Inc.
3 Jan 24
Proxy related to merger
8:00am
health records encompassing medical history, medication history and comorbidities.
Central to GEDi Cube’s mission is its multidisciplinary team
PREM14A
RENB
Renovaro Inc.
22 Dec 23
Preliminary proxy related to merger
5:25pm
encompassing medical history, medication history and comorbidities.
Central to GEDi Cube’s mission is its multidisciplinary team and its proprietary AI
DEFA14A
RENB
Renovaro Inc.
11 Dec 23
Additional proxy soliciting materials
5:15pm
mission has shifted and the vision of Renovaro has shifted to and I believe this is possible, freeing us from toxic chemotherapy in our lifetime … of newspapers regularly with challenging things. In crises, the most important thing is to stay focused on what your mission is, to remain humble and learn
DEFA14A
RENB
Renovaro Inc.
2 Nov 23
Additional proxy soliciting materials
5:29pm
with GEDi Cube Intl Ltd., an AI medical technology company. Investors can expect this partnership to accelerate our mission by mutually reinforcing AI
DEFA14A
EX-99.1
bl6wkrrrox5 8h
4 Oct 23
Additional proxy soliciting materials
4:20pm
425
EX-99.1
88po6onm8d6v0
2 Oct 23
Business combination disclosure
9:28am
8-K
EX-99.1
8n3yymij6q2jfcbe3jy
2 Oct 23
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
9:26am
8-K
620j 7jqxfv
9 Aug 23
Regulation FD Disclosure
9:05am
8-K
EX-99.1
xi2ejtar
15 Mar 22
Other Events
7:00am
8-K
EX-99.1
yvxz1mmq0o64uwcjfa
1 May 19
Regulation FD Disclosure
5:09pm
8-K
EX-99.2
5ct993jh6o329unwh16v
7 Mar 19
Regulation FD Disclosure
12:36pm
8-K
8fp38910ro
1 Mar 19
Regulation FD Disclosure
12:00am
8-K
EX-99.1
51to9b
11 Feb 19
Regulation FD Disclosure
8:25am
8-K
EX-99.1
fv4 2a31mrjo5v9rktx
6 Dec 18
Enochian Biosciences Announces Uplisting to Nasdaq
11:15am